MX2020011557A - Complejos de oro ciclometalados de (s^c) que contienen un ligando 1,1-ditio, así como, el conjugado o composiciones que comprende dichos complejos y el uso de los mismos en el tratamiento de infecciones causadas por bacterias multirresistentes o como antibiopelícula. - Google Patents

Complejos de oro ciclometalados de (s^c) que contienen un ligando 1,1-ditio, así como, el conjugado o composiciones que comprende dichos complejos y el uso de los mismos en el tratamiento de infecciones causadas por bacterias multirresistentes o como antibiopelícula.

Info

Publication number
MX2020011557A
MX2020011557A MX2020011557A MX2020011557A MX2020011557A MX 2020011557 A MX2020011557 A MX 2020011557A MX 2020011557 A MX2020011557 A MX 2020011557A MX 2020011557 A MX2020011557 A MX 2020011557A MX 2020011557 A MX2020011557 A MX 2020011557A
Authority
MX
Mexico
Prior art keywords
gold
iii
complex
conjugate
preparing
Prior art date
Application number
MX2020011557A
Other languages
English (en)
Spanish (es)
Inventor
González Sara María Soto
Loncán Carlos Ratia
López Virginio Cepas
Cubillos Yuly López
ORTÍZ Fernando LÓPEZ
Valdés-Solís María José Iglesias
Soengas Raquel María González
Original Assignee
Univ Almeria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Almeria filed Critical Univ Almeria
Publication of MX2020011557A publication Critical patent/MX2020011557A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/12Gold compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/02Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups A01N57/10, A01N57/18, A01N57/26, A01N57/34
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/02Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups A01N57/10, A01N57/18, A01N57/26, A01N57/34
    • A01N57/08Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups A01N57/10, A01N57/18, A01N57/26, A01N57/34 containing heterocyclic radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/67Phosphorus compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5463Compounds of the type "quasi-phosphonium", e.g. (C)a-P-(Y)b wherein a+b=4, b>=1 and Y=heteroatom, generally N or O
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
MX2020011557A 2018-05-03 2019-04-29 Complejos de oro ciclometalados de (s^c) que contienen un ligando 1,1-ditio, así como, el conjugado o composiciones que comprende dichos complejos y el uso de los mismos en el tratamiento de infecciones causadas por bacterias multirresistentes o como antibiopelícula. MX2020011557A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382305.3A EP3564246B1 (en) 2018-05-03 2018-05-03 A gold(iii) complex, a conjugate of the gold(iii) complex, a pharmaceutical composition comprising the gold(iii) complex and uses and a process for preparing the gold(iii) complex
PCT/EP2019/060879 WO2019211222A1 (en) 2018-05-03 2019-04-29 A gold(iii) complex, a conjugate of the gold(iii) complex, a pharmaceutical composition comprising the gold(iii) complex and uses and a process for preparing the gold(iii) complex

Publications (1)

Publication Number Publication Date
MX2020011557A true MX2020011557A (es) 2021-01-29

Family

ID=62222548

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011557A MX2020011557A (es) 2018-05-03 2019-04-29 Complejos de oro ciclometalados de (s^c) que contienen un ligando 1,1-ditio, así como, el conjugado o composiciones que comprende dichos complejos y el uso de los mismos en el tratamiento de infecciones causadas por bacterias multirresistentes o como antibiopelícula.

Country Status (10)

Country Link
US (1) US11866455B2 (https=)
EP (1) EP3564246B1 (https=)
JP (1) JP7499755B2 (https=)
KR (1) KR20210008020A (https=)
CN (1) CN112638922B (https=)
CA (1) CA3098778A1 (https=)
DK (1) DK3564246T3 (https=)
ES (1) ES2893849T3 (https=)
MX (1) MX2020011557A (https=)
WO (1) WO2019211222A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022072545A1 (en) * 2020-09-29 2022-04-07 University Of Kentucky Research Foundation Multi-coordinate gold-phosphine compounds and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9709471A (es) * 1995-06-07 1998-02-28 Univ Washington Complejos metalicos multidentados y metodos para preparar y usar los mismos.
GB0900961D0 (en) * 2009-01-20 2009-03-04 Univ Bath Antimicrobial coating
WO2013091014A1 (en) * 2011-12-22 2013-06-27 James Cook University Antimicrobial agents

Also Published As

Publication number Publication date
EP3564246B1 (en) 2021-07-07
JP2021523936A (ja) 2021-09-09
ES2893849T3 (es) 2022-02-10
JP7499755B2 (ja) 2024-06-14
CA3098778A1 (en) 2019-11-07
KR20210008020A (ko) 2021-01-20
CN112638922B (zh) 2024-04-05
US11866455B2 (en) 2024-01-09
BR112020022402A2 (pt) 2021-02-02
DK3564246T3 (da) 2021-08-09
US20210188886A1 (en) 2021-06-24
EP3564246A1 (en) 2019-11-06
CN112638922A (zh) 2021-04-09
WO2019211222A1 (en) 2019-11-07

Similar Documents

Publication Publication Date Title
DE602004021472D1 (en) Pyrimiidinverbindungen
GEP20227406B (en) Chromane monobactam compounds for the treatment of bacterial infections
JO2578B1 (en) Compounds Theophene benzimidazole
SG11201810704WA (en) Sulfonamide compound or salt thereof
SA519402288B1 (ar) مركب بيريميدين واستخداماته الصيدلانية
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
MY209256A (en) Compounds affecting pigment production and use thereof for treatment of bacterial diseases
CR20210258A (es) Uso de ciclodextrinas como sistema de suministro de productos agroquímicos
MX2009011493A (es) Complejo de excipiente farmaceutico.
MX2025006620A (es) Compuestos y composiciones como inhibidores de la cinasa c-kit
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
TW200734344A (en) Antibacterial agents
WO2018187331A8 (en) Macrocyclic compound and uses thereof
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
EP3574900A8 (en) New applications of rifamycin-nitroimidazole coupling molecules
MX2024001590A (es) Cianopiridina y degradadores de cianopirimidina bcl6.
MY201377A (en) Compounds and methods for treating bacterial infections
WO2018189661A3 (en) Methods and compounds for treating diabetes
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
MX2021006682A (es) Inhibidores de descarboxilasa para el tratamiento de la enfermedad de parkinson.
GEP20267853B (en) Bicyclic heteroaromatic inhibitors of klk5
MX2023003877A (es) Composiciones que comprenden complejos basados en proteina de union a lipidos para usarse en el tratamiento de enfermedades oculares.
MX2020011557A (es) Complejos de oro ciclometalados de (s^c) que contienen un ligando 1,1-ditio, así como, el conjugado o composiciones que comprende dichos complejos y el uso de los mismos en el tratamiento de infecciones causadas por bacterias multirresistentes o como antibiopelícula.
WO2019236765A8 (en) Acylated catechin polyphenols and methods of their use for the treatment of cancer
WO2017093543A3 (en) Thiol phosphine gold complexes for use in treating bacterial infections